Shake, shake, shake your
NPH insulin pen before injecting
Send a link to a friend
[September 19, 2015]
By Will Boggs MD
(Reuters Health) - A warning for people who use insulin pens: Not
shaking your NPH insulin pen before injecting can result in wide
variations in your insulin level and blood sugar control, researchers
from Italy report.
|
NPH insulin comes as an insoluble mixture of crystals and liquid and
must be resuspended before injection.
Researchers at Perugia University in Italy wanted to know what
difference it would make if patients didn’t resuspend their NPH
insulin by tipping the insulin pen 20 times before injection - and
if they didn’t shake it by tipping it back and forth, whether it
would matter how they held the needle during the injection.
As it turned out, everything mattered.
One of the researchers, Dr. Geremia B. Bolli, told Reuters Health he
was surprised by “the high variability of effects on lowering of
blood glucose depending as to whether the NPH pen is properly
resuspended or not, and (if it’s not resuspended), even great
differences depending on the position of the pen, i.e., horizontal,
vertical with tip up or down.”
“The same NPH appears as a different insulin in each of these
conditions,” Bolli said by email.
Compared with resuspending NPH insulin, not shaking the pen before
injecting could result in lower insulin levels in the blood (if you
inject with the needle flat or pointing up) or higher insulin levels
(if you inject with the needle facing down).
Your body would also feel the effects of insulin earlier if you
injected with the needle down without shaking it first or later if
you injected it flat or needle up without shaking it first.
This could result in your blood sugar rising above desired levels
sooner (needle flat or pointed up) or later (needle pointed down)
when you don’t resuspend the NPH insulin by shaking the pen first.
[to top of second column] |
The research team reported in the journal Diabetes Care that insulin
levels could vary by as much as 23% and blood sugar control could
vary by as much as 62% depending on whether NPH insulin is shaken
before injecting, or not.
“For the users of NPH and also of the pre-mixed insulin (rapid+NPH)
it is important to resuspend carefully prior to injection,” Dr.
Bolli concluded. “This will reduce variability of NPH effects a
lot.”
Dr. Satoru Yamada from Kitasato Institute Hospital, Tokyo, Japan,
who was not involved in this study, told Reuters Health by email
that the results show it's very difficult to have stable efficacy
with NPH insulin.
Yamada advises doctors to select long-acting analogs rather than NPH
itself.
Bolli agrees that it’s great if patients can afford the newer
glargine and detemir forms of insulin, but he points out that for
many patients, these alternatives are beyond their means. And for
these patients, the message is clear: always resuspend your NPH
insulin before injecting.
SOURCE: http://bit.ly/1iVKsv8 Diabetes Care, online September 10,
2015.
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|